ACovPid | Against Virus | Inhibition Value Type | Inhibitory Effect | Inhibitory Unit |   Target Domain Name | Detail |
---|---|---|---|---|---|---|
ACoVP100421 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 3.14 ± 0.5 | µM | HR2 domain of SARS-CoV-2 | more |
ACoVP100422 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >20 | µM | HR2 domain of SARS-CoV-2 | more |
ACoVP100423 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >20 | µM | HR2 domain of SARS-CoV-2 | more |
ACoVP100424 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 3.45 ± 0.52 | µM | HR2 domain of SARS-CoV-2 | more |
ACoVP100425 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >20 | µM | HR2 domain of SARS-CoV-2 | more |
ACoVP100426 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >20 | µM | HR2 domain of SARS-CoV-2 | more |
ACoVP100427 | Transmissible gastroenteritis virus (TGEV) : 11151 | IC50 | ~11.07 | µM | Interaction with TGEV spike glycoprotein domain | more |
ACoVP100428 | Transmissible gastroenteritis virus (TGEV) : 11151 | IC50 | ~15 | µM | Interaction with TGEV spike glycoprotein domain | more |
ACoVP100429 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | >100 | µM | RBD of SARS-CoV-2 | more |
ACoVP100430 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 100 | µM | RBD of SARS-CoV-2 | more |
ACoVP100431 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 100 | µM | RBD of SARS-CoV-2 | more |
ACoVP100432 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 100 | µM | RBD of SARS-CoV-2 | more |
ACoVP100433 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 3.6 | µM | RBD of SARS-CoV-2 | more |
ACoVP100434 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 28.4 | µM | RBD of SARS-CoV-2 | more |
ACoVP100435 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 46.8 | µM | RBD of SARS-CoV-2 | more |
ACoVP100436 | Severe acute respiratory syndrome coronavirus (SARS-CoV) : 694009 | EC50 | 41.6 | µM | RBD of SARS-CoV-2 | more |
ACoVP100437 | Murine coronavirus (strain A59) (MHV-A59) (Murine hepatitis virus) : 11142 | IC50 | 60.6 | µM | more | |
ACoVP100438 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.035 | µM | RBD of SARS-CoV-2 | more |
ACoVP100439 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.0155 | µM | RBD of SARS-CoV-2 | more |
ACoVP100440 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.000024 | µM | RBD of SARS-CoV-2 | more |